Concepedia

Real-World Efficacy and Safety of Inclisiran

Paola Gargiulo, Federica Marzano, Mario Crisci, Rossella Marcucci, Dario Bruzzese, Alessandro Maloberti, Filippo M. Sarullo, Gennaro Galasso, Giuseppe Musumeci, Antonella Corleto,

Journal of the American College of Cardiology · 2024 · 20 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

Italian register of patients treated with inclisiran. real world dataon efficacy and safety

References

9

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

, , +17

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

Scott M. Grundy, Neil J. Stone, Alison Bailey et al. · Journal of the American College of Cardiology · 2018 · 2.6K citations · Full text

, , +10

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

Kausik K. Ray, R. Scott Wright, David Kallend et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text

, , +17

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

Kausik K. Ray, Ulf Landmesser, Lawrence A. Leiter et al. · New England Journal of Medicine · 2017 · 977 citations · Full text

, , +17

Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

Kausik K. Ray, Roel P T Troquay, Frank L.J. Visseren et al. · The Lancet Diabetes & Endocrinology · 2023 · 308 citations · Full text

, , +17